Format
Sort by
Items per page

Send to

Choose Destination

Best matches for alzheimer's glutathione review:

The emerging role of glutathione in Alzheimer's disease. Saharan S et al. J Alzheimers Dis. (2014)

Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress. Rosales-Corral S et al. Oxid Med Cell Longev. (2015)

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease. Peter C et al. Curr Alzheimer Res. (2015)

Search results

Items: 1 to 20 of 199

1.

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration.

Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR.

Front Neurosci. 2018 Jul 10;12:466. doi: 10.3389/fnins.2018.00466. eCollection 2018. Review.

2.

The sinister face of heme oxygenase-1 in brain aging and disease.

Schipper HM, Song W, Tavitian A, Cressatti M.

Prog Neurobiol. 2018 Jul 28. pii: S0301-0082(18)30055-8. doi: 10.1016/j.pneurobio.2018.06.008. [Epub ahead of print] Review.

PMID:
30009872
3.

Genetic polymorphism of glutathione S-transferases: Relevance to neurological disorders.

Dasari S, Gonuguntla S, Ganjayi MS, Bukke S, Sreenivasulu B, Meriga B.

Pathophysiology. 2018 Jun 11. pii: S0928-4680(17)30179-7. doi: 10.1016/j.pathophys.2018.06.001. [Epub ahead of print] Review.

PMID:
29908890
4.

Brain Metabolic, Structural, and Behavioral Pattern Learning for Early Predictive Diagnosis of Alzheimer's Disease.

Mandal PK, Shukla D.

J Alzheimers Dis. 2018;63(3):935-939. doi: 10.3233/JAD-180063.

PMID:
29630555
5.

Determination of parameters of oxidative stress in vitro models of neurodegenerative diseases-A review.

Feitosa CM, da Silva Oliveira GL, Cavalcante AN, Chaves SKM, Rai M.

Curr Clin Pharmacol. 2018 Feb 28. doi: 10.2174/1574884713666180301091612. [Epub ahead of print]

PMID:
29493463
6.

α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review.

Seifar F, Khalili M, Khaledyan H, Amiri Moghadam S, Izadi A, Azimi A, Shakouri SK.

Nutr Neurosci. 2017 Nov 29:1-11. doi: 10.1080/1028415X.2017.1386755. [Epub ahead of print]

PMID:
29185388
7.

Evaluation of the Neuroprotective Potential of N-Acetylcysteine for Prevention and Treatment of Cognitive Aging and Dementia.

Hara Y, McKeehan N, Dacks PA, Fillit HM.

J Prev Alzheimers Dis. 2017;4(3):201-206. doi: 10.14283/jpad.2017.22.

PMID:
29182711
8.

Fatty Acids, Antioxidants and Physical Activity in Brain Aging.

Freitas HR, Ferreira GDC, Trevenzoli IH, Oliveira KJ, de Melo Reis RA.

Nutrients. 2017 Nov 20;9(11). pii: E1263. doi: 10.3390/nu9111263. Review.

9.

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.

Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD.

Cell. 2017 Oct 5;171(2):273-285. doi: 10.1016/j.cell.2017.09.021. Review.

PMID:
28985560
10.

Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.

Manyevitch R, Protas M, Scarpiello S, Deliso M, Bass B, Nanajian A, Chang M, Thompson SM, Khoury N, Gonnella R, Trotz M, Moore DB, Harms E, Perry G, Clunes L, Ortiz A, Friedrich JO, Murray IVJ.

Curr Alzheimer Res. 2018;15(2):164-181. doi: 10.2174/1567205014666170921122458.

11.
12.

Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress.

Ahmadinejad F, Geir Møller S, Hashemzadeh-Chaleshtori M, Bidkhori G, Jami MS.

Antioxidants (Basel). 2017 Jul 10;6(3). pii: E51. doi: 10.3390/antiox6030051. Review.

13.

Why does Finland have the highest dementia mortality rate? Environmental factors may be generalizable.

Eiser AR.

Brain Res. 2017 Sep 15;1671:14-17. doi: 10.1016/j.brainres.2017.06.032. Epub 2017 Jul 5. Review.

PMID:
28687259
14.

A systematic review and meta-analysis of the circulatory, erythrocellular and CSF selenium levels in Alzheimer's disease: A metal meta-analysis (AMMA study-I).

Reddy VS, Bukke S, Dutt N, Rana P, Pandey AK.

J Trace Elem Med Biol. 2017 Jul;42:68-75. doi: 10.1016/j.jtemb.2017.04.005. Epub 2017 Apr 23. Review.

PMID:
28595794
15.

Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease.

Chaudhari KS, Tiwari NR, Tiwari RR, Sharma RS.

Ann Neurosci. 2017 May;24(2):111-122. doi: 10.1159/000475900. Epub 2017 May 12. Review.

16.

Targeting Free Radicals in Oxidative Stress-Related Human Diseases.

Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M.

Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24. Review.

PMID:
28551354
17.

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease.

Agrawal M, Ajazuddin, Tripathi DK, Saraf S, Saraf S, Antimisiaris SG, Mourtas S, Hammarlund-Udenaes M, Alexander A.

J Control Release. 2017 Aug 28;260:61-77. doi: 10.1016/j.jconrel.2017.05.019. Epub 2017 May 24. Review.

PMID:
28549949
18.

Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles.

Nazıroğlu M, Muhamad S, Pecze L.

Expert Rev Clin Pharmacol. 2017 Jul;10(7):773-782. doi: 10.1080/17512433.2017.1324781. Epub 2017 May 16. Review.

PMID:
28463572
19.

The effect of N-acetylcysteine (NAC) on human cognition - A systematic review.

Skvarc DR, Dean OM, Byrne LK, Gray L, Lane S, Lewis M, Fernandes BS, Berk M, Marriott A.

Neurosci Biobehav Rev. 2017 Jul;78:44-56. doi: 10.1016/j.neubiorev.2017.04.013. Epub 2017 Apr 21. Review.

PMID:
28438466
20.

Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases.

Sun Y, Yang T, Leak RK, Chen J, Zhang F.

CNS Neurol Disord Drug Targets. 2017;16(3):326-338. doi: 10.2174/1871527316666170102120211. Review.

Supplemental Content

Loading ...
Support Center